12 Diphtheria Symptoms You Must Recognize

Diphtheria may seem like a disease from the past, but it still poses a significant threat in many parts of the world. With the rise of vaccine-preventable diseases, diphtheria is one illness that has become less common in places with widespread immunization

However, in areas with low vaccination rates, diphtheria remains a serious and potentially deadly condition. Caused by the bacteria Corynebacterium diphtheriae, this infection primarily affects the respiratory system, but it can also impact the skin, heart, and nerves.

One of the challenges of diphtheria is that its symptoms can appear gradually, often starting with something as simple as a sore throat or mild fever. These early signs might be easily confused with other respiratory infections, which is why recognizing the distinct symptoms of diphtheria early is critical.

The disease’s hallmark symptom is a thick grayish coating that forms in the throat or nose, which can cause breathing difficulties and lead to severe complications. As the infection spreads, it can release toxins that affect the heart, nerves, and kidneys, making it more dangerous than many might initially realize.

While diphtheria can affect anyone, it is particularly harmful to those who have not been vaccinated. If left untreated, the toxin produced by the bacteria can cause damage to vital organs and lead to respiratory failure. This makes early detection and treatment essential for preventing life-threatening complications.

In this article, we will highlight the 12 diphtheria symptoms you must recognize, so you can take action before the disease progresses. If you or someone you know exhibits these signs, seeking immediate medical attention can make all the difference.

Table of Contents

12 Primary Symptoms of Diphtheria

Sore Throat

This is often the very first symptom to appear. Initially, it may be mild, similar to a common cold, but it typically worsens rapidly over one to two days. The pain can become quite severe, making it difficult to speak or swallow.

The throat and tonsils will appear red and swollen upon inspection. This inflammation is a direct result of the bacteria multiplying on the mucous membranes and beginning to produce the diphtheria toxin, which damages local tissues.

Mild Fever and Chills

Diphtheria typically causes a low-grade fever, usually around 100.4°F (38°C), although it can sometimes be higher. This is accompanied by chills as the body attempts to fight off the infection.

Unlike the high, spiking fevers associated with some other bacterial infections, the relatively mild fever in the early stages of diphtheria can give a false sense of security, masking the true severity of the illness.

Fatigue and Malaise

A profound sense of fatigue, weakness, and general malaise is a hallmark of diphtheria’s onset. This is more than just feeling tired; it is a deep-seated exhaustion caused by the body’s immune response and the initial effects of the circulating diphtheria toxin.

This systemic feeling of being unwell is often disproportionate to the mildness of the other initial symptoms and serves as a significant warning that something more serious than a simple viral infection is occurring.

Thick, Gray Pseudomembrane

This is the most characteristic and dangerous sign of diphtheria. The diphtheria toxin causes localized cell death, leading to the formation of a dense, leathery, gray-to-black sheet covering the tonsils, pharynx, larynx, and even the nasal passages.

This pseudomembrane is composed of dead cells, fibrin, white blood cells, and bacteria. It adheres tightly to the underlying tissue, and attempting to scrape it away causes bleeding. As it grows, it can obstruct the airway, leading to suffocation—a primary cause of death in severe diphtheria cases.

Difficulty Swallowing (Dysphagia)

The presence of the thick pseudomembrane, combined with severe swelling and inflammation of the throat tissues, makes swallowing extremely painful and difficult. Patients may complain of a sensation of a lump in their throat.

This dysphagia can lead to dehydration and malnutrition, further weakening the patient’s ability to fight the infection. The pain can be so intense that even swallowing saliva becomes a challenge.

Hoarse Voice and Croup-like Cough

When the infection and the pseudomembrane extend down to the larynx (voice box), it interferes with the function of the vocal cords, resulting in a hoarse voice (dysphonia). The inflammation and obstruction can also lead to a distinctive, harsh, barking cough, often described as croupy.

This indicates laryngeal diphtheria, a particularly dangerous form of the disease because of the high risk of complete airway obstruction from the swelling and membrane formation in this narrow part of the respiratory tract.

Swollen Neck Glands (Bull Neck)

This is a classic and ominous sign of severe, toxic diphtheria. The diphtheria toxin causes a massive, tender swelling of the lymph nodes in the neck (cervical lymphadenopathy) and surrounding soft tissues.

This gives the neck a distinctively swollen and edematous appearance, commonly referred to as a bull neck. This sign indicates a very high level of toxin in the body and is strongly associated with a poor prognosis, as it often precedes severe systemic complications and airway compromise due to external compression.

Difficulty Breathing or Rapid Breathing

Severe difficulty breathing (dyspnea) is one of the most immediate life-threatening symptoms of advanced diphtheria. It can be caused by two primary mechanisms: the pseudomembrane physically obstructing the airway or pieces of the membrane breaking off and being inhaled deeper into the lungs.

The body compensates for the lack of oxygen by breathing more rapidly (tachypnea). Stridor, a high-pitched, wheezing sound made during inhalation, is a common sign of significant upper airway obstruction and indicates an impending respiratory arrest.

Bluish Skin Color (Cyanosis)

Cyanosis is a visible sign of dangerously low oxygen levels in the blood. When the airway is severely obstructed, the blood cannot be adequately oxygenated in the lungs. This deoxygenated blood is darker in color, causing the skin, lips, and nail beds to take on a bluish or purplish tint.

The appearance of cyanosis is a late-stage sign of respiratory failure and a critical warning that the patient is on the verge of suffocation. It is an absolute medical emergency requiring immediate intervention to restore a patent airway.

Painful, Ulcer-like Sores

The infection typically begins at the site of a pre-existing skin break, such as a cut, scrape, or insect bite. The area becomes red, swollen, and tender.

Over time, it develops into one or more pustules or shallow ulcers with clearly defined, punched-ou” borders. These lesions are often painful and can be chronic, lasting for weeks or even months if left untreated. They are most commonly found on the legs, feet, and hands.

Gray Membrane Formation

Similar to respiratory diphtheria, a gray or yellowish-gray membrane may form over the surface of the skin ulcer. This membrane is composed of dead tissue, bacteria, and inflammatory cells and adheres to the base of the sore.

While not as thick or extensive as the pseudomembrane seen in the throat, its presence is a key diagnostic clue for cutaneous diphtheria. The surrounding skin is often inflamed and edematous.

Chronic and Contagious Nature

A defining feature of cutaneous diphtheria is the chronic, non-healing nature of the ulcers. Without appropriate antibiotic treatment, these sores can persist for a long time. Throughout this period, the lesions are teeming with Corynebacterium diphtheriae and are highly contagious through direct contact.

An individual with cutaneous diphtheria can easily transmit the bacteria to an unvaccinated or susceptible person, who may then develop the more dangerous respiratory form of the disease. Therefore, identifying and treating these skin lesions is crucial for both the individual’s health and public health.

What is The Definition of Diphtheria?

Diphtheria is defined as an acute infectious disease caused by specific strains of the bacterium Corynebacterium diphtheriae that are capable of producing a potent cytotoxin known as the diphtheria toxin. It is this toxin, not merely the bacterial presence, that is responsible for the severe, life-threatening manifestations of the disease.

The bacteria typically colonize the upper respiratory tract, where they multiply and release the toxin, leading to local tissue necrosis and the formation of the hallmark pseudomembrane. The toxin can then be absorbed into the bloodstream and distributed throughout the body, causing systemic complications.

The Corynebacterium diphtheriae itself is a club-shaped, Gram-positive, non-motile bacillus. Critically, not all strains of C. diphtheriae cause diphtheria. The ability to produce the diphtheria toxin is conferred upon the bacteria by a specific virus, a bacteriophage, which integrates its genetic material into the bacterium’s DNA.

Only these toxigenic strains are responsible for the severe clinical disease. Non-toxigenic strains can cause milder throat infections or skin lesions but do not lead to the classic, life-threatening form of diphtheria.

Moreover, the diphtheria toxin is an incredibly potent exotoxin that functions by inhibiting protein synthesis within human cells, leading to rapid cell death (necrosis). When released in the throat, it kills the epithelial cells of the mucous membranes, triggering an inflammatory response that results in the formation of the pseudomembrane.

If absorbed into the bloodstream, the toxin has a particular affinity for certain tissues, leading to serious and often irreversible complications. It can cause myocarditis (inflammation of the heart muscle), which can lead to heart failure and arrhythmias; peripheral neuropathy, causing paralysis (often starting with the palate and later affecting limbs and respiratory muscles); and acute tubular necrosis in the kidneys, leading to kidney failure.

The infection begins when a susceptible individual is exposed to toxigenic C. diphtheriae. The bacteria attach to and multiply on the mucosal surfaces of the respiratory tract. As they grow, they secrete the diphtheria toxin, which initiates the process of local tissue destruction.

This results in the characteristic pseudomembrane, which can cause airway obstruction. The subsequent absorption and systemic circulation of the toxin lead to the potentially fatal damage to distant organs, making diphtheria a classic example of a toxin-mediated disease.

How Does the Diphtheria Bacterium Spread?

Respiratory droplet transmission is the most common way diphtheria is spread. When an infected person coughs, sneezes, or even talks, they expel microscopic droplets containing Corynebacterium diphtheriae into the air.

If a nearby person inhales these droplets, the bacteria can colonize their respiratory tract and initiate an infection. This mode of transmission is most effective in close-quarter environments such as households, schools, and institutional settings. The incubation period after exposure is typically short, ranging from two to five days.

Diphtheria can also be transmitted through direct physical contact with the secretions from an infected person. This includes contact with discharge from the nose or throat, or more commonly, by touching the open, weeping sores of someone with cutaneous (skin) diphtheria.

The bacteria present in the ulcer can easily be transferred to another person’s hands and then to their mouth, nose, or a break in their skin, establishing a new infection. This route is particularly significant in tropical regions and areas with inadequate sanitation and hygiene.

While less common, the diphtheria bacteria can survive for a short period on dry surfaces. This means it is possible, though rare, to become infected by touching objects that have been recently contaminated with an infected person’s secretions, such as used tissues, drinking glasses, utensils, or toys, and then touching one’s own mouth, nose, or eyes.

Furthermore, some individuals can be asymptomatic carriers, harboring the bacteria in their nose and throat without showing any symptoms of illness. These carriers can unknowingly transmit the bacteria to others, making disease control more challenging.

The highly contagious nature of the bacteria, combined with the potential for asymptomatic carriers, makes it a significant public health threat in communities with low vaccination coverage. Transmission typically requires close contact with an infected individual, which is why outbreaks are often seen in crowded living conditions.

Diphtheria Diagnosis

Confirming a diphtheria infection involves a multi-step process that combines physical examination with specific laboratory tests, as the initial symptoms can overlap with other respiratory illnesses. A healthcare provider will first conduct a thorough physical exam, paying close attention to the throat, tonsils, and neck.

The most telling clinical sign is the presence of a pseudomembrane – a thick, gray, leathery coating covering the back of the throat, tonsils, or nasal passages. If a doctor suspects diphtheria based on this membrane and other symptoms like a sore throat, low-grade fever, and swollen neck glands (“bull neck”), they will proceed with diagnostic testing without delay.

The primary test is a bacterial culture, where a swab sample is taken from the throat membrane or a skin lesion. This sample is sent to a laboratory where technicians attempt to grow and identify the Corynebacterium diphtheriae bacteria.

Because the danger of diphtheria comes from the toxin produced by the bacteria, not just the bacteria itself, further testing is essential. To determine if the specific strain of bacteria is toxigenic, laboratories perform a toxin assay.

The Elek test involves placing a strip of filter paper saturated with diphtheria antitoxin onto a culture plate where the bacteria are growing. If the bacteria produce the toxin, a visible line of precipitate forms where the toxin and antitoxin meet, confirming a toxigenic strain.

Moreover, modern diagnostics often use Polymerase Chain Reaction (PCR) tests to detect the gene (tox gene) responsible for toxin production directly from the patient’s sample. This method is faster and more sensitive than traditional culture methods.

Since laboratory confirmation can take time, treatment with antitoxin is often started based on strong clinical suspicion alone. Delaying treatment while waiting for test results can allow the toxin to cause irreversible damage to the heart, nerves, and kidneys.

Diphtheria and Strep Throat

While both diphtheria and strep throat are bacterial infections that cause a severe sore throat, they are caused by different organisms and present with distinct, critical differences. Differentiating between them is crucial because their treatments and potential complications vary significantly. The most definitive distinguishing feature is the appearance of the throat.

Diphtheria is characterized by the formation of a pseudomembrane, a thick, gray or blackish, sheet-like covering that adheres tightly to the tissues of the throat and tonsils. Attempting to scrape this membrane off often causes bleeding.

In contrast, strep throat, caused by Streptococcus pyogenes, typically presents with bright red, inflamed tonsils that may be covered in white spots or streaks of pus, known as tonsillar exudates. The roof of the mouth may also have tiny red spots called petechiae.

Next, diphtheria’s potent toxin can cause systemic symptoms not seen in typical strep throat. One of the most alarming is severe neck swelling, often called a bull neck, caused by massively enlarged lymph nodes. This can lead to airway obstruction. Strep throat causes swollen lymph nodes, but not to this extreme degree.

Strep throat is often accompanied by a sudden high fever, headache, and body aches, but usually not a cough. Diphtheria disease symptoms may start more gradually with a low-grade fever, and respiratory diphtheria can be associated with a brassy, croup-like cough and difficulty breathing if the membrane obstructs the airway.

Specially, diphtheria is caused by toxin-producing strains of Corynebacterium diphtheriae, and its life-threatening complications are a direct result of the toxin spreading through the bloodstream.

Strep throat is caused by Streptococcus pyogenes and, while it can lead to complications like rheumatic fever or kidney disease, it does not produce a toxin that causes the same type of acute, systemic organ damage as diphtheria.

Diphtheria Treatments

The medical treatment for diphtheria is a time-sensitive, two-pronged approach that aims to neutralize the circulating bacterial toxin and eliminate the bacteria causing the infection.

The first and most critical component of treatment is the administration of diphtheria antitoxin (DAT). This antitoxin is not an antibiotic; it is a preparation of antibodies that specifically target and neutralize the diphtheria toxin that has not yet bound to the body’s cells.

By inactivating the free-floating toxin in the bloodstream, DAT prevents further damage to vital organs like the heart, nervous system, and kidneys. Because its effectiveness depends on administering it as early as possible, doctors will typically give DAT based on a strong clinical suspicion of diphtheria, often before laboratory results can confirm the diagnosis. The risk of waiting for confirmation is far greater than the risk of administering the antitoxin.

The second essential component of treatment is a course of antibiotics. While antibiotics have no effect on the already-produced toxin, they are crucial for several reasons.

Antibiotics, such as penicillin (administered intravenously or intramuscularly) or erythromycin, kill the Corynebacterium diphtheriae bacteria. This stops the bacteria from producing any more toxin, thereby halting the progression of the disease at its source.

By eliminating the bacteria, antibiotics make the patient non-contagious, typically within 48 hours of starting treatment. This is vital for preventing the spread of the disease to family members, healthcare workers, and the wider community.

In addition to these primary treatments, patients with diphtheria require close monitoring and supportive care in a hospital setting. This may include bed rest, respiratory support if the pseudomembrane obstructs the airway, and cardiac monitoring to watch for signs of myocarditis (inflammation of the heart muscle), a common and dangerous complication.

How to Prevent Diphtheria Effectively

Vaccination is overwhelmingly effective and is the single most important tool for preventing diphtheria. The dramatic decline of this once-common and deadly disease in many parts of the world is a direct result of widespread childhood immunization programs.

Diphtheria vaccines work by introducing the body to a toxoid, which is a chemically inactivated form of the diphtheria toxin. This toxoid is not harmful and cannot cause disease, but it triggers the immune system to produce protective antibodies.

If a vaccinated person is later exposed to the actual Corynebacterium diphtheriae bacteria, these antibodies are ready to immediately neutralize the toxin before it can cause any damage. This is why vaccination prevents the severe, life-threatening aspects of the disease, even if a person still becomes a carrier of the bacteria.

The vaccines that protect against diphtheria are typically given in combination with vaccines for other diseases, and the specific formulation depends on the person’s age. Following the recommended schedule is crucial for establishing and maintaining immunity.

DTaP (Diphtheria, Tetanus, and acellular Pertussis) is administered to infants and young children in a series of five doses, typically at 2, 4, and 6 months, between 15-18 months, and again between 4-6 years of age.

Next, Tdap (Tetanus, Diphtheria, and acellular Pertussis)is a booster shot recommended for preteens (around ages 11-12), pregnant women during each pregnancy, and any adult who has not previously received it. It provides continued protection for diphtheria while also boosting immunity against tetanus and pertussis (whooping cough).

After receiving the Tdap booster, adults should receive a (Tetanus and Diphtheria) Td booster every 10 years to maintain their immunity against both tetanus and diphtheria. This ongoing protection is essential, as immunity can wane over time, leaving adults vulnerable.

FAQs

1. What is C. diphtheria?

C diphtheria refers to the bacterium Corynebacterium diphtheriae, which is the primary cause of diphtheria. This bacterium produces toxins that can cause severe damage to the respiratory system, leading to swelling, difficulty breathing, and the formation of a thick grayish membrane in the throat.

The toxins can also spread throughout the body, causing damage to other organs, including the heart, kidneys, and nerves. Understanding C. diphtheria and its impact on the body is essential in preventing and treating this potentially deadly disease.

2. How do you define diphtheria?

Diphtheria is a serious bacterial infection caused by Corynebacterium diphtheriae. It primarily affects the throat and nasal passages but can also spread to other parts of the body. Symptoms include a sore throat, fever, swelling in the neck, and the formation of a thick, gray membrane in the throat.

The bacteria produce toxins that damage tissues and can lead to life-threatening complications, such as heart failure, kidney damage, and nerve impairment. Timely diagnosis and treatment are crucial to preventing the spread of this disease.

3. What kills diphtheria?

Diphtheria is treated with a combination of diphtheria antitoxin, which neutralizes the toxins produced by the bacteria, and antibiotics such as penicillin or erythromycin to kill the bacteria. Prompt administration of these treatments can significantly reduce the severity of the illness and prevent complications.

Early intervention is essential, as diphtheria can be fatal if not treated quickly. Vaccination with the DTaP vaccine is the most effective way to prevent diphtheria and protect against the disease.

4. Can you fully recover from diphtheria?

Yes, many people can fully recover from diphtheria, especially when treated early. Recovery depends on how quickly treatment is started, the severity of the symptoms, and the individual’s overall health.

Diphtheria may cause long-term complications, such as nerve damage, heart issues, or kidney problems, but with prompt treatment, many individuals recover without lasting effects. Vaccination is key to preventing the disease in the first place and avoiding its potentially serious consequences.

5. What can be mistaken for diphtheria?

Diphtheria can be mistaken for several other conditions, including strep throat, tonsillitis, mononucleosis, and viral pharyngitis. These conditions share common symptoms such as sore throat, fever, and swelling.

However, the hallmark of diphtheria is the formation of a grayish membrane in the throat, which sets it apart from other infections. Since early diagnosis is critical, it’s important to seek medical attention if symptoms are severe or do not improve with treatment.

6. How long is diphtheria contagious?

A person with diphtheria is contagious for as long as they are showing symptoms, and up to 2 weeks after the infection begins. However, once the person starts receiving appropriate antibiotic treatment, they are usually no longer contagious after 48 hours. It’s essential to isolate individuals with diphtheria until they have completed at least 48 hours of antibiotic treatment to prevent the spread of the bacteria.

7. Is diphtheria the same as tuberculosis (TB)?

No, diphtheria and tuberculosis (TB) are two distinct diseases caused by different types of bacteria. Diphtheria is caused by Corynebacterium diphtheriae, while tuberculosis is caused by Mycobacterium tuberculosis. Both diseases can affect the respiratory system, but they have different symptoms, causes, and treatments.

Diphtheria often presents with a grayish membrane in the throat, while TB typically causes a persistent cough, night sweats, and weight loss.

8. How fatal is diphtheria?

Without proper treatment, diphtheria can be fatal. The disease can lead to severe complications such as respiratory failure, heart failure, and nerve damage. Historically, diphtheria was a leading cause of death in children, but thanks to widespread vaccination, the number of cases has dramatically decreased.

However, diphtheria remains a serious risk in areas with low vaccination coverage. Early diagnosis and treatment are critical to preventing life-threatening complications.

9. What country did diphtheria come from?

Diphtheria has been known for centuries and was first described in Europe. The disease became widespread in the 19th century, particularly in areas with poor sanitation.

Today, diphtheria is rare in countries with high vaccination rates, but it still occurs in regions with limited access to vaccines. Diphtheria was first officially documented in Europe and spread throughout the world before the introduction of the DTaP vaccine in the 20th century.

Conclusion

Diphtheria is a serious bacterial infection that requires prompt attention and treatment to prevent severe complications. Recognizing the symptoms early, such as the characteristic throat membrane and fever, is crucial for timely intervention.

While diphtheria can be fatal without treatment, vaccination has significantly reduced the incidence of the disease worldwide. Understanding the importance of vaccination and staying informed about potential risks can help protect you and your loved ones from this potentially deadly illness.

If you or someone you know is showing symptoms of diphtheria, seeking medical help immediately can make all the difference in preventing long-term damage and ensuring a full recovery.

References:

Disclaimer This article is intended for informational and educational purposes only. We are not medical professionals, and this content does not replace professional medical advice, diagnosis, or treatment. The goal is to provide accurate, evidence-based information to raise awareness of causes of pancreatitis. If you are experiencing persistent, severe, or concerning symptoms, you should seek guidance from a qualified healthcare provider. Read the full Disclaimer here →

12 Diphtheria Symptoms You Must Recognize